News & Commentary
Physicians don’t think highly about the ability of electronic health records (EHRs) to support clinical outcomes, according to Deloitte’s “2016 Survey of U.S. Physicians.” Less than half (47%) of physicians agree that EHR capabilities improve clinical outcomes. That’s down from the 2014 survey, in which 55% of physicians believed the same.

Sepsis contributes to nearly half of hospital deaths in the United States, and now a drug company wants to try something new against this deadly infection of the blood: cutting-edge cancer immunotherapies, STAT reports.

Original Research
Sze-jung Wu, PhD
;
Qinli Ma, PhD
;
Patricia Martin, RN, BSN
;
Andrea DeVries, PhD
Value-based centers of excellence programs offer an advance over programs that focus only on cost or quality alone in the ability to identify facilities with lower costs and equal or better quality outcomes. Value designation offers patients transparency for selecting care providers.

More trouble for the ACA marketplace: Consumers are having a difficult time finding doctors because the lists offered are inaccurate, Kaiser Health News reports. This is occurring despite new federal rules designed to guarantee reliable physician directories.  

Had your fill of the courtroom drama surrounding the proposed merger of Anthem and Cigna? Well, now it’s time for the drama surrounding the proposed merger of Aetna and Humana, another instance where the Justice Department charges that such a move violates antitrust law.

MediMedia Research Survey
Respondents to the survey of medical directors and chief medical directors officers rated their organization’s commitment to value-based care as high, a development that will mean grappling with the cost implications of clinical policies and practices. A third said a large percentage (41% or higher) of their job concerns the financial performance of their organization.

The brouhaha generated by Turing Pharmaceuticals and Valeant Pharmaceuticals this year because they jacked up some older medicines they’d purchased to head-line grabbing heights may have provided cover for the rest of the industry, according to Leonard Schleifer, MD, the head of Regeneron Pharmac

Legislation & Regulation
Richard Mark Kirkner
Because hospital spending makes up the largest piece of U.S. health care spending—32%, according to data from CMS—any judicial rulings or legislative move to curb a hospital’s market dominance are key to controlling overall health care costs. The FTC is stepping in.

The American Medical Association (AMA) is being inundated by tweets from doctors furious that the organization supports the nomination of Republican House Budget Committee Chairman Tom Price for secretary of the Health and Human Services Department, according to STAT.

Medical Director Profiles
Howard Wolinsky

Neal Kaufman, MD

“My job as CMO is to make sure we’re keeping the patient at the center—that our products make sense to them and to clinicians,” he says. Canary’s programs come from protocols that have been vetted by scientists, clinicians, and patients over many years, if not decades.
Medical Director Profiles
Howard Wolinsky

Steve Miller, MD

“Some days I’m out supporting our sales people and trying to acquire new business. Some days I’m with our legal teams trying to help them decipher new regulations. Some days I am with our supply team group negotiating with the pharmaceutical companies.”